Malaysia Property News is a free resource website sharing Daily Property News & information about Property in Malaysia, which related to, Property Market, Property Investment, Commercial Property , Hot Properties Malaysia, Real Estate, Retail Shop, Business Park, Condominium Malaysia, Terraces & Apartment Malaysia, Houses, Residence, Resort and many more.

Thursday, December 17, 2009

Setia Haruman throws in perks for buyers of CBD Perdana 2 units

Investors looking for a blue chip commercial property to add to their portfolio can check out Setia Haruman Sdn Bhd's latest project, CBD Perdana 2 in Cyberjaya, Selangor.

Under the first phase, it had generated gross returns of about 10 per cent per year for its owners. CBD Perdana 2 promises to offer a similar competitive investment advantage and equally good returns.

In a statement, Setia Haruman said CBD Perdana 2 is based on an award-winning "Office Park" con-cept evolving around an architectural design that creates a "green and vibrant" work environment.

Expected to be completed by October 2011, CBD Perdana 2 is touted to be the new commercial highlight of Cyberjaya; offering signature retail space and corporate office units.

The built-up area of the units ranges from 2,2821,776 sq ft to 2,5733,121 sq ft.
Located within the central business district of Cyberjaya, CBD Perdana 2 enjoys a ready consumer catchment from the 900,000 population of Cyberjaya, Putrajaya, Kajang, Seri Kembangan, Puchong and Dengkil; accessibility via major highways; and comprehensive facilities in the neighbourhood such as an international school and three private established universities and colleges.

Setia Haruman, which is the master developer of Cyberjaya, said rental returns of CBD Perdana 2 are expected to be RM3 and above per sq ft.

For a limited time only, purchasers of CBD Perdana 2 units will get to enjoy various incentives under a flexible financial package offered at attractive interest rates; with zero progressive interest during construction.

By Business Times

No comments: